UBS Group’s Acumen Pharmaceuticals ABOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $110K | Sell |
94,422
-28,593
| -23% | -$33.2K | ﹤0.01% | 5899 |
|
|
2025
Q1 | $135K | Sell |
123,015
-18,477
| -13% | -$20.3K | ﹤0.01% | 5555 |
|
|
2024
Q4 | $243K | Buy |
141,492
+118,741
| +522% | +$204K | ﹤0.01% | 5144 |
|
|
2024
Q3 | $56.4K | Buy |
22,751
+9,965
| +78% | +$24.7K | ﹤0.01% | 5536 |
|
|
2024
Q2 | $30.9K | Buy |
12,786
+6,143
| +92% | +$14.9K | ﹤0.01% | 5888 |
|
|
2024
Q1 | $26.9K | Buy |
6,643
+6,635
| +82,938% | +$26.9K | ﹤0.01% | 5611 |
|
|
2023
Q4 | $31 | Sell |
8
-92
| -92% | -$357 | ﹤0.01% | 7821 |
|
|
2023
Q3 | $415 | Buy |
+100
| New | +$415 | ﹤0.01% | 7363 |
|
|
2023
Q2 | – | Sell |
-3,137
| Closed | -$12.7K | – | 7734 |
|
|
2023
Q1 | $12.7K | Buy |
+3,137
| New | +$12.7K | ﹤0.01% | 6337 |
|
|
2022
Q4 | – | Sell |
-2,687
| Closed | -$27K | – | 9472 |
|
|
2022
Q3 | $27K | Buy |
+2,687
| New | +$27K | ﹤0.01% | 5895 |
|
|
2022
Q2 | – | Sell |
-5,245
| Closed | -$21K | – | 9183 |
|
|
2022
Q1 | $21K | Buy |
5,245
+4,388
| +512% | +$17.6K | ﹤0.01% | 6340 |
|
|
2021
Q4 | $6K | Buy |
857
+247
| +40% | +$1.73K | ﹤0.01% | 8121 |
|
|
2021
Q3 | $9K | Buy |
+610
| New | +$9K | ﹤0.01% | 6929 |
|